NASDAQ:OSUR
OraSure Technologies Stock News
$4.86
-0.185 (-3.67%)
At Close: May 10, 2024
OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
06:00am, Friday, 29'th Jan 2021
This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek
OTTAWA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical s
BETHLEHEM, Pa., Jan. 26, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
OraSure's Oragene®•Dx Saliva Collection Kit Included in Industry's First FDA Authorization for a Whole Exome Sequencing Platform
06:00am, Thursday, 21'st Jan 2021
BETHLEHEM, Pa., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
OraSure: Well Positioned Ex-Covid, Sell Side Missing The Organic Growth Drivers
12:58pm, Tuesday, 12'th Jan 2021
OraSure: Well Positioned Ex-Covid, Sell Side Missing The Organic Growth Drivers
OraSure Technologies Announces 2021 Annual Meeting Date
06:00am, Friday, 08'th Jan 2021
BETHLEHEM, Pa., Jan. 08, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
06:00am, Tuesday, 05'th Jan 2021
BETHLEHEM, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and a
OraSure's OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
06:00am, Wednesday, 23'rd Dec 2020
OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical s
BETHLEHEM, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today disclosed that the U.S. F
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference
07:00am, Monday, 30'th Nov 2020
BETHLEHEM, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephe
Stock Upgrades: Orasure Technologies Shows Rising Relative Strength
03:52pm, Monday, 09'th Nov 2020
A Relative Strength Rating upgrade for Orasure Technologies shows improving technical performance. The post Stock Upgrades: Orasure Technologies Shows Rising Relative Strength appeared first on Invest
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q3 2020 Results - Earnings Call Transcript
08:58pm, Wednesday, 04'th Nov 2020
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q3 2020 Results - Earnings Call Transcript
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments
04:01pm, Wednesday, 04'th Nov 2020
Net T hird Q uarter R evenues of $ 48.0 M illion Increased 33 % Year-Over-Year, D riven by $ 18 . 4 M illion in S ales of O ral F luid C ollection D evices for COVID-19 M olecular T esting
Second FDA EUA for the Subsidiary's Saliva Collection Devices Second FDA EUA for the Subsidiary's Saliva Collection Devices
OraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:OSUR)
11:26am, Thursday, 22'nd Oct 2020
OraSure receives emergency use authorization for OMNIgene. Keros Therapeutics initiates Phase 2 clinical trial for Myelodysplastic Syndromes.
